Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria

J Gen Intern Med. 2021 Sep;36(9):2915-2917. doi: 10.1007/s11606-021-06871-w. Epub 2021 Jun 14.

Authors

Stephanie A Patrick¹, Tracey D Dabal¹, Christopher D Jackson^{2

3}

Affiliations

¹ Department of Medicine, Division of General Internal Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA.
² Department of Medicine, Division of General Internal Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA. [email protected].
³ UTHSC Internal Medicine Residency, Memphis, TN, USA. [email protected].

No abstract available

MeSH terms

Albuminuria / drug therapy
Benzhydryl Compounds / therapeutic use
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Glomerular Filtration Rate
Glucosides / therapeutic use
Humans
Kidney
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy

Substances

Benzhydryl Compounds
Glucosides
dapagliflozin